In vitro efficacy of lufenuron against filamentous fungi and blood concentrations after PO administration in horses

Journal of Veterinary Internal Medicine

Volumn 19, Issue 6, 2005, Pages 878-882

  Scotty, Nicole C ^a,d   Evans, Tim J ^a   Giuliano, Elizabeth ^a   Johnson, Philip J ^a   Rottinghaus, George E ^a   Fothergill, Annette W ^b   Cutler, Tim J ^c  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Texas Health Science Center   (United States)

^c Animal Eye Specialty Clinic   (United States)

^d Florida Veterinary Specialists   (United States)

Author keywords

Antifungal; Aspergillus; Endometritis; Equine; Fusarium; Keratitis; Sinusitis

Indexed keywords

BENZAMIDE DERIVATIVE; FLUPHENACUR; INSECTICIDE;

ANIMAL; ARTICLE; ASPERGILLUS; BLOOD; CLINICAL TRIAL; DRUG EFFECT; FEMALE; FUSARIUM; HORSE; MALE; MICROBIOLOGY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; ASPERGILLUS; BENZAMIDES; FEMALE; FUSARIUM; HORSES; INSECTICIDES; MALE;

ASPERGILLUS; EQUIDAE; EQUUS CABALLUS; FUNGI; FUSARIUM;

EID: 28444436625     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2005)19[878:IVEOLA]2.0.CO;2     Document Type: Article

References (21)

1. Hess MB, Parker NA, Purswell BJ, et al. Use of lufenuron as a treatment for fungal endometritis in four mares. J Am Vet Med Assoc 2002;15:266-267.
2. Cohen E. Interference with chitin biosynthesis in insects. In: Wright JE, Retnakaran A, eds. Chitin and Benzoylphenyl Ureas, Series Entomologica, Vol 38. Boston, MA: Dr W Junk Publishers; 1987:33-42.
3. Ben-Ziony Y, Arzi B. Use of lufenuron for treating fungal infections of dogs and cats: 297 cases (1997-1999). J Am Vet Med Assoc 2000;217:1510-1513.
4. Dubuis E, Lucas D. Control of cutaneous mycosis in five chimpanzees (Pan troglodytes) with lufenuron. Vet Rec 2003;152:651-654.
5. Didier ES, Maddry JA, Kwong CD, et al. Screening of compounds for antimicrosporidial activity in vitro. Folia Parasitol (Praha) 1998;45:129-139.
6. DeBoer DJ, Moriello KA, Blum JL, et al. Effects of lufenuron treatment in cats on the establishment and course of Microsporum canis infection following exposure to infected cats. J Am Vet Med Assoc 2003;222:1216-1220.
7. Byron B, Lindsay D. Ectoparasiticides. In: Adams HR, ed. Veterinary Pharmacology and Therapeutics, 8th ed. Ames, IA: Iowa State University Press; 2001:1017-1039.
8. MacKichan JJ, Hink W. High-performance liquid Chromatographic determination of CGA-184699 (lufenuron) in dog and cat blood. J Liq Chromatogr 1993;16:2595-2604.
9. Hink WF, Zakson M, Barnett S, et al. Evaluation of a single oral dose of lufenuron to control flea infestations in dogs. Am J Vet Res 1994;55:822-824.
10. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi Approved Standard M-38A. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
11. Gill JL, Hafs HD. Analysis of repeated measurements of animals. J Anim Sci 1971;33:331.
12. Brooks DE, Andrew SE, Dillavou CL, et al. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis. Am J Vet Res 1998;59:138-142.
13. Hector RF, Zimmer BL, Pappagianis D, et al. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother 1990;34:587-593.
14. Beauvais A, Latge JP. Membrane and cell wall targets in Aspergillus fumigatus. Drug Resist Update 2001;4:38-49.
15. Dean SR, Meola RW, Meola SM, et al. Mode of action of lufenuron on larval cat fleas (Siphonaptera: Pulicidae). J Med Entomol 1998;35:720-724.
16. Ruiz-Herrera J, San-Blas G. Chitin synthesis as target for antifungal drugs. Curr Drug Targets Infect Disord 2003;3:77-91.
17. Roncero C. The genetic complexity of chitin synthesis in fungi. Curr Genet 2002;41:367-378.
18. Cabib E. Differential inhibition of chitin synthetases 1 and 2 from Saccharomyces cerevisiae by polyoxin D and nikkomycins. Antimicrob Agents Chemother 1991;35:170-173.
19. Maertens JA, Boogaerts MA. Fungal cell wall inhibitors: Emphasis on clinical aspects. Curr Pharm Des 2000;6:225-239.
20. Stevens DA. Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens. Antimicrob Agents Chemother 2000;44:2547-2548.
21. Riviere JE. Comparative Pharmacokinetics: Principles, Techniques, and Applications. Ames, IA: Iowa State University Press; 1999:27-29.